Inflammation after spinal cord injury: a review of the critical timeline of signaling cues and cellular infiltration

• Published in: Journal of neuroinflammation 2021-12, Vol.18 (1), p.284-16, Article 284
• Main Authors: Hellenbrand, Daniel J, Quinn, Charles M, Piper, Zachariah J, Morehouse, Carolyn N, Fixel, Jordyn A, Hanna, Amgad S
• Format: Article
• Language: English
• Subjects: Animal models; Animals; Apoptosis; Astrocytes - metabolism; Blood vessels; Cell death; Cellular signal transduction; Chemokines; Complications and side effects; Cytokines; Cytokines - metabolism; Development and progression; Edema; Excitotoxicity; Inflammation; Inflammation - etiology; Inflammation - metabolism; Ischemia; Macrophages; Microglia; Microglia - metabolism; Neurological research; Recovery of Function; Regeneration; Review; Secondary cascade; Signal Transduction - physiology; Spinal cord injuries; Spinal Cord Injuries - complications; Spinal Cord Injuries - metabolism; Spinal cord injury; Therapeutic targets; Trauma; Tumor necrosis factor-TNF
• ISSN: 1742-2094; 1742-2094
• DOI: 10.1186/s12974-021-02337-2

Traumatic spinal cord injury (SCI) is a devastating neurological condition that results in a loss of motor and sensory function. Although extensive research to develop treatments for SCI has been performed, to date, none of these treatments have produced a meaningful amount of functional recovery after injury. The primary injury is caused by the initial trauma to the spinal cord and results in ischemia, oxidative damage, edema, and glutamate excitotoxicity. This process initiates a secondary injury cascade, which starts just a few hours post-injury and may continue for more than 6 months, leading to additional cell death and spinal cord damage. Inflammation after SCI is complex and driven by a diverse set of cells and signaling molecules. In this review, we utilize an extensive literature survey to develop the timeline of local immune cell and cytokine behavior after SCI in rodent models. We discuss the precise functional roles of several key cytokines and their effects on a variety of cell types involved in the secondary injury cascade. Furthermore, variations in the inflammatory response between rats and mice are highlighted. Since current SCI treatment options do not successfully initiate functional recovery or axonal regeneration, identifying the specific mechanisms attributed to secondary injury is critical. With a more thorough understanding of the complex SCI pathophysiology, effective therapeutic targets with realistic timelines for intervention may be established to successfully attenuate secondary damage.